More stories

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around Its Role in...

Last month, psychedelic drug developer MindMed scored an FDA breakthrough therapy designation for its LSD-D-tartrate candidate (MM120) in the treatment of generalised anxiety disorder...

Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood

In this episode, Alexa interviews creative entrepreneur, veteran of the cannabis space, and now, founder of SetSet, an educational platform and podcast (picking up...

Natural Medicine Advisory Bulletin 10: March 2024

Written by the Vicente LLP team as part of our Colorado Natural Medicine Health Act Tracker. The primary focus of the March 15th meeting...

Is Cannabis a Psychedelic?

While psychoactive substances like psilocybin and MDMA have taken the spotlight as frontrunners in psychedelic-assisted therapy, the growing impact of cannabis in combating treatment-resistant...

Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program

Last month, a Utah bill that creates a pilot program for two healthcare systems to offer MDMA and psilocybin treatments became law in the...

The Alexander Shulgin Research Institute and the Future of Psychedelic Drug Development

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his...

The Psychedelic News Feed: April 1, 2024

This is a special version of our Psychedelic News Feed to mark April 1st, 2024. ∎ Coming Soon: Interdimensional Patent Tracker Our friends at...

Pα+ Psychedelic Patent Analysis: February 2024

In this issue of the Psychedelic Patent Analysis, we look at IP and exclusivity in MDMA drug development across Lykos, atai, MindMed, Arcadia, and...

PT499 – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological Turn

In this episode, David interviews Osiris González Romero: philosopher and Postdoctoral researcher on cognitive freedom and psychedelic humanities at the University of Saskatchewan. Romero...

Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK? Beckley Shares Cut...

Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: Lykos Therapeutics, MDMA-assisted therapy; Compass Pathways; COMP360; MHRA; Beckley Psytech;...

The Practitioner’s Guide to Psychedelic Integration Therapy

Psychedelics on their own can’t save people from chronic depression. Therapists alone can’t do it either. However, entheogens can spark the journey toward wholeness,...

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence “Insufficient”

Yesterday, the Institute for Clinical and Economic Review (ICER) published its draft evidence report on MDMA-assisted psychotherapy (which it abbreviates to ‘MDMA-AP’) for the...

Most popular